Mark R. Charbonneau

5.2k total citations · 4 hit papers
16 papers, 3.2k citations indexed

About

Mark R. Charbonneau is a scholar working on Molecular Biology, Nutrition and Dietetics and Clinical Biochemistry. According to data from OpenAlex, Mark R. Charbonneau has authored 16 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Nutrition and Dietetics and 4 papers in Clinical Biochemistry. Recurrent topics in Mark R. Charbonneau's work include Gut microbiota and health (7 papers), Metabolism and Genetic Disorders (4 papers) and Diet and metabolism studies (4 papers). Mark R. Charbonneau is often cited by papers focused on Gut microbiota and health (7 papers), Metabolism and Genetic Disorders (4 papers) and Diet and metabolism studies (4 papers). Mark R. Charbonneau collaborates with scholars based in United States, Australia and Finland. Mark R. Charbonneau's co-authors include Jeffrey I. Gordon, Sathish Subramanian, Andrew L. Goodman, Michael Rosenbaum, Janaki L. Guruge, José C. Clemente, Andrew C. Heath, Henning Seedorf, Jeremiah J. Faith and Rudolph L. Leibel and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mark R. Charbonneau

13 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Long-Term Stability of the Human Gut Microbiota

2013 1.5k citations Jeremiah J. Faith, Janaki L. Guruge et al. Science profile →
Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children

2016 542 citations Laura V. Blanton, Mark R. Charbonneau et al. Science profile →
Developing a new class of engineered live bacterial therapeutics to treat human diseases

2020 313 citations Mark R. Charbonneau, Vincent M. Isabella et al. Nature Communications profile →
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

2019 280 citations Caroline Kurtz, Yves Millet et al. Science Translational Medicine profile →

Peers

Mark R. Charbonneau

PHYSI

Amanda E. Ramer‐Tait United States

Shai Fuchs Canada

Mahesh S. Desai Luxembourg

Annick Bernalier‐Donadille France

Pamela Vernocchi Italy

Samuel C. Forster Australia

Parameth Thiennimitr Thailand

Florian Chain France

Martin Iain Bahl Denmark

Amanda E. Ramer‐Tait United States

Mark R. Charbonneau

2.7k ×1.1

567 ×0.9

731 ×1.1

PHYSI

628 ×1.3

546 ×1.1

Citations per year, relative to Mark R. Charbonneau Mark R. Charbonneau (= 1×) peers Amanda E. Ramer‐Tait

Countries citing papers authored by Mark R. Charbonneau

Since Specialization

Citations

This map shows the geographic impact of Mark R. Charbonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Charbonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Charbonneau more than expected).

Fields of papers citing papers by Mark R. Charbonneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Charbonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Charbonneau. The network helps show where Mark R. Charbonneau may publish in the future.

Co-authorship network of co-authors of Mark R. Charbonneau

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Charbonneau. A scholar is included among the top collaborators of Mark R. Charbonneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Charbonneau. Mark R. Charbonneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Schott, Eric M., Mark R. Charbonneau, Douglas P. Kiel, et al.. (2025). A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women. Osteoporosis International. 36(10). 2019–2030.

Murphy, Vincent A., Alicia E. Ballok, Maria J. Soto-Girón, et al.. (2024). Food safety assessment and 28-day toxicity study of the synbiotic medical food consortium SBD121. Food and Chemical Toxicology. 191. 114839–114839. 2 indexed citations

Lubkowicz, David, Michael J. James, Ron B. Shmueli, et al.. (2022). An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria. Molecular Systems Biology. 18(3). e10539–e10539. 35 indexed citations

Charbonneau, Mark R., et al.. (2021). Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria. Communications Biology. 4(1). 898–898. 13 indexed citations

Puurunen, Marja, Jerry Vockley, Stephanie Sacharow, et al.. (2021). Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nature Metabolism. 3(8). 1125–1132. 105 indexed citations

Charbonneau, Mark R., et al.. (2021). Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip. Nature Communications. 12(1). 2805–2805. 54 indexed citations

Charbonneau, Mark R.. (2021). A Mechanistic Model to Predict Synthetic Biotic Activity in Healthy Volunteers and Patients with Phenylketonuria. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

Lubkowicz, David, Michael J. James, Mark R. Charbonneau, et al.. (2020). Development of a Synthetic Biotic, SYNB8802, for the Treatment of Enteric Hyperoxaluria. Journal of the American Society of Nephrology. 31(10S). 245–245.

Charbonneau, Mark R., Vincent M. Isabella, Ning Li, & Caroline Kurtz. (2020). Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nature Communications. 11(1). 1738–1738. 313 indexed citations breakdown →

10.

Kurtz, Caroline, Yves Millet, Marja Puurunen, et al.. (2019). An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Science Translational Medicine. 11(475). 280 indexed citations breakdown →

11.

Charbonneau, Mark R., Laura V. Blanton, Daniel B. DiGiulio, et al.. (2016). A microbial perspective of human developmental biology. Nature. 535(7610). 48–55. 166 indexed citations

12.

Blanton, Laura V., Mark R. Charbonneau, Tarek Salih, et al.. (2016). Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science. 351(6275). 542 indexed citations breakdown →

13.

Blanton, Laura V., Michael J. Barratt, Mark R. Charbonneau, Tahmeed Ahmed, & Jeffrey I. Gordon. (2016). Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics. Science. 352(6293). 1533–1533. 156 indexed citations

14.

Subramanian, Sathish, Laura V. Blanton, Steven A. Frese, et al.. (2015). Cultivating Healthy Growth and Nutrition through the Gut Microbiota. Cell. 161(1). 36–48. 119 indexed citations

15.

Charbonneau, Mark R.. (2015). Characterizing the Role of Sialylated Milk Glycans and the Infant Gut Microbiota in Growth and Metabolism. Open Scholarship Institutional Repository (Washington University in St. Louis). 1 indexed citations

16.

Faith, Jeremiah J., Janaki L. Guruge, Mark R. Charbonneau, et al.. (2013). The Long-Term Stability of the Human Gut Microbiota. Science. 341(6141). 1237439–1237439. 1460 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact